Established, Scalable & Rapidly-Growing
CritiTech Particle Engineering Solutions (CT PES) is an established, growing, pharmaceutical Contract Development Manufacturing Organization (CDMO) with extensive experience and expertise in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing. The company utilizes Spray Drying and Supercritical Precipitation to help its customers develop their drugs. CT PES provides its drug development and manufacturing services from proof-of-concept through Phase II cGMP production. It has produced cGMP materials related to four drugs that are currently being tested in a total of six clinical trials. Clients range from three “Top 15” pharmaceutical companies to pharmaceutical and biotechnology start-ups. CT PES is located in Lawrence, Kansas, home of the University of Kansas School of Pharmacy.
CritiTech Particle Engineering Solutions has assembled a team with deep pharmaceutical experience whose number one priority is serving the drug development needs of our clients. Our talented and driven staff has decades of experience in particle engineering, early stage drug development, formulation, material characterization, analytical testing, pre-clinical and clinical manufacturing, quality operations and corporate management serving positions at Sandoz, Sanofi-Aventis, Merck, Cardinal Health, Celliance, Quintiles, CareFusion and Plastikon.